The rise of drug-resistant infections poses a severe threat to global public health. Antimicrobial resistance (AMR) is a broad term encompassing resistance to antibiotics, antivirals, antifungals, and antiparasitics. Overuse and misuse of antimicrobial agents in human health, agriculture, and veterinary practices contribute to the accelerated development of resistance. The emergence of multidrug-resistant strains, commonly observed in bacteria such as Methicillin-resistant Staphylococcus aureus (MRSA) and extensively drug-resistant tuberculosis (XDR-TB), challenges the effectiveness of standard treatments. This phenomenon leads to prolonged illness, increased healthcare costs, and higher mortality rates. The lack of new antimicrobial drugs in the pharmaceutical pipeline exacerbates the problem, emphasizing the urgent need for research and development in this field. Global initiatives like the World Health Organization's Global Action Plan on AMR underscore the importance of a coordinated, multisectoral approach to combat drug resistance.